A model epitope-tagged receptor was constructed by fusing the hemagglutinin (HA) sequence on the extracellular Nterminus of the human somatostatin receptor subtype 2 (hSSTr2) gene. This construct was placed in an adenoviral (Ad-HAhSSTr2) vector. This study evaluated Ad-HAhSSTr2 in vitro and in vivo using FACS, fluorescent microscopy, radioactive binding assays, and gamma camera imaging techniques. Infection of A-427 non-small cell lung cancer cells with Ad-HAhSSTr2 or Ad-hSSTr2 resulted in similar expression of hSSTr2 by FACS analysis and binding assays using a 
Introduction
There are currently more than 2000 patients enrolled in Phase I and Phase II clinical gene therapy trials. 1 A majority of these patients are being treated for neoplastic disease and require tumor and tissue biopsies to confirm gene transfer by assaying for mRNA or protein products. In vivo imaging of gene transfer using reporter genes and reporter substrates should have a tremendous impact on clinical gene therapy trials due to the ability to noninvasively quantitate the level of gene transfer over time. In this regard, our group and several others have utilized optical, magnetic, or nuclear imaging techniques to evaluate gene transfer in animal models.
Optical imaging has focused on green fluorescent protein (GFP) and luciferase as reporter genes. [2] [3] [4] [5] [6] [7] These techniques offer high spatial resolution, but may be difficult to quantitate and detect depending upon the depth issue in animal models. The transferrin receptor and b-galactosidase have been used as reporter genes for magnetic resonance imaging with iron oxide nanoparticles and a gadolinium chelate, respectively. 8, 9 Magnetic resonance spectroscopy has been used to detect gene transfer using cytosine deaminase, arginine kinase, and the murine creatine kinase as reporter genes. [10] [11] [12] These studies observed the changes in chemical shift of the 19 F or the 31 P isotopes. However, these magnetic strategies have limited temporal resolution and sensitivity.
In general, the most common nuclear imaging techniques have used either enzymes or receptors as reporter genes. The herpes simplex virus type 1 thymidine kinase (HSV1-tk) has been used extensively as a reporter enzyme with radiolabeled 2 0 -fluoro-2 0 deoxy-1-b-D-arabinofuranosyl-5-iodouracil, 8-fluoro-ganciclovir, 8-fluoropenciclovir, 9-[(3-fluoro-1-hydroxy-2-propoxy)-methyl] guanine or 9-(4-fluoro-3-hydroxymethylbutyl)guanine as reporter substrates for gamma camera or positronemission tomography (PET) imaging. [13] [14] [15] [16] [17] [18] [19] [20] [21] This system has been improved with the use of a mutant HSV1-tk reporter gene (HSV1-sr39tk) that enhances the intracellular trapping of reporter substrates. The type 2 dopamine receptor (D 2 R) and the human somatostatin receptor subtype 2 (hSSTr2) have also been used as reporter genes. 3-(2 0 -18   F-fluoroethylspiperone and   11   Craclopride have been used to image D 2 R by PET,   18,22,23   while   99m   Tc-P829,  188 Re-P829,   99m   Tc-P2045, and   111 In-DTPA-D-Phe 1 -octreotide have been used to image hSSTr2 with a gamma camera. [24] [25] [26] Also, it has been demonstrated that two genes can be expressed simultaneously either through the use of an internal ribosomal entry site or by placing each gene in series under the control of separate promoters. 14, 26, 27 Other reporter gene systems for nuclear imaging have included the sodium iodide symporter and carcinoembryonic antigen. 28, 29 Our interests have focused on imaging hSSTr2 expression in vivo after infection with adenoviral vectors encoding the gene for hSSTr2. 24, 25, 30 However, it is known that hSSTr2 is naturally expressed on a number of tissues and, therefore, ectopic expression of hSSTr2 may have physiological consequences from interactions with native hSSTr2 ligands. In this regard, a reporter receptor that could be used to non-invasively image gene transfer without having a biological effect may be advantageous. This investigation describes a first step toward this goal by constructing an adenovirus encoding for an epitopetagged receptor. The epitope-tagged receptor consists of hSSTr2 that contains the influenza virus hemagglutinin (HA) sequence at the N-terminus. In this context, the HA epitope would be novel and not found in normal tissues and, therefore, would be a specific marker for determining gene transfer. The adenovirus encoding the epitopetagged receptor (Ad-HAhSSTr2) was evaluated in vitro for the expression of hSSTr2 and HA using radiolabeled binding and internalization assays and flow cytometry analyses. The expression of HA was then evaluated in vivo in normal and tumor-bearing mice after Ad-HAhSSTr2 administration by non-invasively imaging with an Anger gamma camera using a 99m Tc-labeled anti-HA monoclonal antibody ( 99m Tc-anti-HA). Thus, these studies demonstrate the feasibility of expressing a novel receptor epitope on cells in vitro and in vivo using an adenovirus vector for the purpose of determining the level and persistence of gene transfer using external gamma camera imaging.
Results

In vitro FACS analysis of hSSTr2 and HAhSSTr2 expression
A-427 cells infected at multiplicity of infection (MOI) of 10 with Ad-hSSTr2 or Ad-HAhSSTr2 without the addition of the primary antibodies had a low mean fluorescence intensity (MFI) (o9.0) (Figure 1 ). Analysis of A-427 cells with the anti-HA antibody (a) after infection with increasing amounts of Ad-HAhSSTr2 showed an increase in the MFI from 54.6 at 1 MOI to 644.9 at 100 MOI. However, when the cells were infected with increasing amounts of Ad-hSSTr2, an increase in the amount of anti-HA binding was not observed. Infection of A-427 cells with increasing amounts of either AdHAhSSTr2 or Ad-hSSTr2 resulted in increases in binding of the anti-hSSTr2 antibody (b) for both of the viruses. The binding of the anti-hSSTr2 antibody was significantly greater (Po0.003) after infection with Ad-hSSTr2 at 10 and 100 MOI compared to Ad-HAhSSTr2 infection. Tc-P2045 for cells infected with Ad-hSSTr2 was 21.6 7 14.4nM compared to a K d of 13.9 7 6.7nM after infection with Ad-HAhSSTr2. The B max after infection with Ad-hSSTr2 (41,044 7 10,774 fmol/mg) was not significantly different from that after infection with AdHAhSSTr2 (33,298 7 7,270 fmol/mg). The amount of internalized 99m Tc-P2045 into A-427 cells at 371C was similar after infection with either Ad-HAhSSTr2 or Ad-hSSTr2 at peptide concentrations less than 1.5 nM (Figure 4 ). There was B0.45% dose/mg of internalized radioactivity at low concentrations of Imaging gene transfer with an anti-HA antibody BE Rogers et al compared to B0.15% dose/mg at high concentrations. There were significant differences (Po0.03) in internalization at concentrations greater than 1.5 nM.
Confocal microscopy of HAhSSTr2 expression
In vitro binding of 99m
Tc-anti-HA to infected A-427 cells Tc-anti-HA to cells infected with Ad-HAhSSTr2 at 371C was B0.60% dose/mg compared to o0.12% dose/mg at 01C. When the cells were infected with Ad-hSSTr2, the acid-resistant binding was o0.004% dose/mg at both temperatures, significantly lower (Po0.05) than cells infected with AdHAhSSTr2. Note that although the absolute binding was greatest at high concentrations ( Figure 5b , Lane 3) after Ad-HAhSSTr2 infection, the percent binding of total radioactivity added was the lowest (Figure 5c ). These results correlated with the confocal microscopy images, which showed that the anti-HA antibody was not internalized at 371C and that no binding occurred after infection with Ad-hSSTr2. Tc-anti-HA by 10 min. The accumulation was the result of HAhSSTr2 expression in the liver, which was confirmed by immunohistochemistry ( Figure 6c ). The green staining on hepatocytes was specific for HA expression and was absent in the liver of mice injected with Ad-hSSTr2 (data not shown). A lesser amount of staining was seen occasionally in sinusoidal cells in mice injected with AdHAhSSTr2. Staining was barely detectable in the spleen (not shown) and was not seen in the other organs examined (including lung, heart). These results demonstrate the expression of HAhSSTr2 in the liver that was Tc-anti-HA averaged 53.6 7 6.9% ID/g in the liver for animals previously injected with Ad-HAhSSTr2, significantly higher (Po0.05) than 9.0 7 1.3% ID/g in the liver of mice injected with Ad-hSSTr2. In contrast, the Ad-hSSTr2-injected mice showed high 99m Tc-anti-HA in blood averaging 37.5 7 2.5% ID/g. This blood level was significantly higher (Po0.05) than the 99m Tc-anti-HA blood level that averaged 5.3 7 2.9% ID/g for animals injected with Ad-HAhSSTr2. In fact, the concentration of 99m Tc-anti-HA was significantly greater (Po0.05) in all tissues after Ad-hSSTr2 infection compared to AdHAhSSTr2 infection except for the liver and spleen.
The gamma camera imaging and biodistribution results from a second experiment using a subcutaneous tumor model are shown in Figure 7 . The position of a representative mouse for gamma camera imaging and size of the tumors is shown in Figure 7a . Figure 7b is an image taken immediately after the injection of 31 In addition, they stated that the expression level on these cells was 10,400 fmol/mg, which is lower than the 33,300 fmol/mg reported in this study after infecting A-427 cells with Ad-HAhSSTr2 at 10 MOI.
The FACS results in Figure 1 show an increase in HAhSSTr2 expression upon increasing the MOI of AdHAhSSTr2 from 1 to 100. When these results are expressed as the % positive cells (determined by gating the right-hand tail of the distribution of the negative control at 1%), it showed that 470% of the cells were positive for HAhSSTr2 after infection at 1 MOI and 495% were positive after infection at 10 or 100 MOI. This is in agreement with previously published data that demonstrate 495% of A-427 cells express green fluorescent protein (GFP) after infection with an adenovirus encoding GFP at 10 MOI. 33 Thus, these results suggest that the increase in expression of HAhSSTr2 from 1 to 10 MOI is a function of increasing the number of cells infected and possibly the number of receptors per cell, while the increase of HAhSSTr2 from 10 to 100 MOI is a function of increasing the number of receptors per cell since 495% of the cells are infected. This is likely due to multiple infections of the same cell by Ad-HAhSSTr2.
The results from Figures 1 and 3 suggest that expression of hSSTr2 is greater than the expression of HAhSSTr2 after infection with Ad-hSSTr2 and AdHAhSSTr2, respectively. Figure 1 shows significantly greater expression of hSSTr2 after infection at 10 and 100 MOI, while Figure 3 shows greater expression of hSSTr2 after infection at 10 MOI, although this does not reach significance. There may be several reasons for these differences. One explanation may be that the HA tag may cause differences in the transcription of the cDNA and translation to the HAhSSTr2 protein. Another may be that the HA tag affects the binding of the anti-hSSTr2 polyclonal antibody used in the FACS assay, but not the P2045 peptide used in the saturation binding assay. Further studies are necessary to determine the reason for these differences. Tc-anti-HA in the liver and its clearance from the blood. Due to this rapid uptake, imaging was not conducted at longer time points. Expression of HA in the liver after Ad-HAhSSTr2 injection was confirmed by immunohistochemistry (Figure 6c ) which showed expression limited to the hepatocytes. The imaging results were confirmed upon tissue biodistribution (Figure 6d ) and the greater concentration of 99m Tc-anti-HA in tissues after Ad-hSSTr2 infection compared to Ad-HAhSSTr2 infection was due to the extraction of 99m Tc-anti-HA from the blood into the liver in Ad-HAhSSTr2-infected animals. This rapid extraction was likely due to the high expression of HAhSSTr2 on hepatocytes which were sufficient to remove most of the 99m Tc-anti-HA from the circulation within 10 min after injection. In fact, based on the specific activity of the 99m Tc-anti-HA and the % ID/g in the liver after correction for blood, it is estimated that there were approximately 15,000 receptors per hepatocyte assuming 20% of the hepatocytes express HAhSSTr2 (Figure 6c ) and there are 1 Â 10 9 cells/g. Furthermore, the liver:blood ratio in animals injected with Ad-hSSTr2 was 0.24 which is similar to the 0.21 reported previously 10 min after injection of the 99m Tc-HSA blood pool agent. 38 By contrast, the liver:blood ratio was 10.1 after injection of Ad-HAhSSTr2 which shows the specificity of 99m Tc-anti-HA localization. These studies demonstrate Tc-anti-HA by non-invasively imaging with a gamma camera.
A second in vivo experiment was conducted to evaluate the expression of HAhSSTr2 in mice bearing subcutaneous A-427 xenografts. These studies utilized an intratumoral injection of Ad-HAhSSTr2 or Ad-hSSTr2 as previously described. 24, 26 This showed that the tumors injected with Ad-HAhSSTr2 could be clearly visualized by gamma camera imaging 25 h after injection of Tc-P829 (another hSSTr2-binding peptide) in Ad-hSSTr2-infected A-427 tumors (2.5% ID/g) 24 and comparable to the uptake of 99m
Tc-P2045 in Ad-hSSTr2-infected A-427 tumors (10.2% ID/ g). 26 This demonstrates that the 99m Tc-anti-HA can achieve tumor uptake as high as the best radiolabeled peptide evaluated. Immunohistochemical analysis was not performed in the tumor as it was in the liver ( Figure  6c) ; however, it is expected that HAhSSTr2 expression would be limited to a focal region along the needle tract and the injection site which was observed previously in the same tumor model using two different adenoviral vectors. 24, 26 These studies show that Ad-HAhSSTr2 can induce tumor expression of HAhSSTr2 after intratumoral injection and that this expression can be imaged with a gamma camera using 99m Tc-anti-HA. It is well established that intact monoclonal antibodies, such as the anti-HA antibody, have long serum halflives. 39 Thus, the high blood concentration of radioactivity observed in Figures 6a and 7c is expected. Since the liver has high blood flow and Ad-HAhSSTr2 infects the liver efficiently leading to high expression of HAhSSTr2, the radioactivity was extracted from the blood rapidly as observed in Figure 6b . In order to increase the tumor-to-background ratio in Figure 7c , it will be necessary to decrease the amount of radioactivity in the blood. This can be accomplished through the use of molecularly engineered antibodies against the HA sequence. Engineered antibodies have been produced that maintain their bivalency, clear the blood more rapidly than intact antibodies 40, 41 and have been radiolabeled for nuclear imaging of tumors. 41 Thus, imaging gene transfer with 99m Tc-labeled anti-HA engineered antibodies should improve the current approach.
It was previously mentioned that using hSSTr2 as a reporter receptor may not be ideal due to the inability to non-invasively image tumors that natively express hSSTr2 or due to undesirable cell signaling effects of hSSTr2. With regard to the latter issue, it has been shown that expression of hSSTr2 has a negative growth effect on cancer proliferation and metastasis. [42] [43] [44] Therefore, the use of hSSTr2 should be advantageous as a reporter receptor in cancer, although there may be concern for its effects in normal tissues. In this regard, it may be advantageous to uncouple ligand binding from signal transduction as suggested by Liang et al and as they have demonstrated with D 2 R. 23 The former is another concern for using hSSTr2 as a reporter receptor, thus, HAhSSTr2 could address this. Insertion of the HA sequence into the N-terminus of the receptor did not appear to have deleterious effects with regard to ligand binding as shown in Figures 3 and 4 . This was expected, as it is known that hSSTr2 ligands bind to hSSTr2 transmembrane domains III-VII distal from the N-terminus. [45] [46] [47] Elimination of hSSTr2 ligand binding by modifying the aspartic acid residue 124 in transmembrane domain III 48, 49 while maintaining the HA epitope would be the next step toward creating a novel receptor for monitoring gene transfer. Since internalization of hSSTr2 is determined by the C-terminal intracellular domain, 50, 51 it will be interesting to determine if this mutation affects the internalization of HAhSSTr2.
Overall, these studies represent a proof of principle for adding a peptide tag to the N-terminus of hSSTr2. It is envisioned that other peptide sequences could be inserted into the N-terminus that are capable of binding a Tc-binding sequences. 52 This suggests that the HA sequence could be substituted with a GGC sequence for complexing 99m Tc in vivo. In addition, this approach may overcome the issue of the potential immunogenicity of the HA tag in the event of using the Ad-HAhSSTr2 in humans.
In conclusion, the construction and evaluation of a novel adenoviral vector encoding for epitope-tagged HAhSSTr2 was described. The expressed hSSTr2 and HA functionality were confirmed using FACS analysis, fluorescent microscopy, and radiolabeled binding and internalization assays. The ability to non-invasively image gene transfer with a gamma camera was shown in both the liver of nude mice and in the tumor of mice bearing xenografts. These studies demonstrate the feasibility of using the HA sequence as a reporter for non-invasively imaging gene transfer. Future studies will optimize this system through the use of better radiolabeled ligands and improvements to the epitopetagged receptor.
Materials and methods
Cell Lines
The A-427 human non-small cell lung cancer cells and the 293 human transformed primary embryonal kidney cells were obtained from American Type Culture Collection (Rockville, MD, USA). Both cell lines were maintained in Eagle's MEM containing 10% fetal bovine serum and 1% L-glutamine. The A-427 media was also supplemented with 1% non-essential amino acids. Both cell lines were cultured at 371C in a humidified atmosphere with 5% CO 2 .
Construction of Ad-HAhSSTr2
The expression plasmid (a+12CA5-KH) containing the HA sequence (YPYDVPDYA) was kindly provided by Kerry J Koller (Affymax Research Institute, Palo Alto, CA, USA). 31 The hSSTr2 gene was obtained by PCR from the pAChSSTr2 plasmid by eliminating the start site and including XhoI and HindII sites for cloning into the a+12CA5-KH plasmid. The HA-hSSTr2 fragment was removed and ligated into the shuttle vector pShuttle-CMV, which is used in the AdEasy system of homoImaging gene transfer with an anti-HA antibody BE Rogers et al logous recombination in bacteria rather than in eucaryotic cells. 53 The pShuttle-CMVHAhSSTr2 plasmid was sequenced, linearized and electroporated into Escherichia coli. BJ5183 cells with the pAdEasy-1 adenoviral plasmid. The bacteria were plated on kanamycin-resistant plates and clones picked to confirm the presence of both hSSTr2 and Ad5 by PCR. The clones were transfected into 293 cells and the resulting recombinant adenovirus plaque purified according to standard techniques. The AdHAhSSTr2 was titered within 293 cells using plaque assay techniques for direct determination of viral pfu. The Ad-hSSTr2 was made as previously described. 54 The mouse anti-HA monoclonal antibody (Babco Inc., Richmond, CA, USA) was conjugated with the HYNIC chelate for complexing 99m Tc. A previously described protocol was used with one exception, 55 during the conjugation the molar ratio of HYNIC:antibody was 8. The specific activity of the antibody was 21.2 7 4.1 mCi/ mg for seven separate radiolabelings.
Radiolabeling of Ligands
In vitro FACS analysis of hSSTr2 and HAhSSTr2 expression
A-427 cells were infected with either Ad-hSSTr2 or AdHAhSSTr2 at 1, 10, or 100 MOI. Forty-eight hours later, the cells were harvested and 2 x 10 5 cells incubated with either the mouse anti-HA monoclonal antibody (1 mg) or a rabbit anti-hSSTr2 polyclonal antibody (1 mg) at 01C in a total volume of 200 ml. Research Genetics (Huntsville, AL, USA) was contracted to produce the anti-hSSTr2 antibody. The cells were rinsed and either a FITC-labeled anti-mouse (2 mg) or a FITC-labeled anti-rabbit secondary antibody (2 mg) was added for 1 h at 01C in a total volume of 200 ml. Controls were conducted at 10 MOI without addition of the primary antibody. The cells were washed and analyzed by the UAB FACS Core Facility to determine the level of hSSTr2 and HAhSSTr2 expression. The data are expressed as the mean fluorescent intensity (MFI).
Confocal microscopy of HASSTR2 expression
A-427 cells were infected with Ad-hSSTr2 or AdHAhSSTr2 at 10 MOI and seeded in six-well plates at 24 h after infection. The six-well plates had glass coverslips at the bottom of the wells for attachment of the cells. Twenty-four hours later, the anti-HA antibody conjugated with FITC (Babco Inc., Richmond, CA, USA) was added (20 nM) to the wells and incubated at 371C for 2 h.
After the incubation, the cells were rinsed twice with PBS and the coverslips were removed. The coverslips were positioned on slides that had 0.5 mm silicon gaskets (silicon sheeting, Molecular Probes, Eugene, OR, USA) in the shape of the coverslip, thereby forming a small chamber between the coverslip and slide. This chamber was filled with PBS. In this manner, the cells remained alive and sealed within the chamber for confocal microscopy studies. Imaging was performed on a Leica DMIRBE inverted epifluorescence/Nomarski microscope outfitted with Leica TCS NT Laser Confocal optics (Leica Inc., Exton, PA, USA). Excitation of FITC was provided with an Argon ion laser using the 488 nm line Precise control of fluorochrome excitation and emission was respectively afforded by an acousto-optical tunable filter and TCS SP prism spectrophotometer.
In vitro binding and internalization of 99m Tc-P2045 into infected A-427 cells For binding assays, A-427 cells were infected for 1 h with either Ad-hSSTr2 or Ad-HAhSSTr2 at 10 MOI. Fortyeight hours later, the cells were harvested for membrane preparations as previously described 54 and a saturation binding assay was performed on 20 mg of the membrane preparation.
99m Tc-P2045 was added (0.1-400 nM) to the membranes with an excess of unlabeled P2045 and incubated at room temperature for 1 h. The membranes were then rinsed to remove unbound radioactivity and counted in a Minaxi Auto-Gamma 5000 series gamma counter (Packard Instrument Co., Downers Grove, IL, USA). Three experiments were performed and plotted as cpm bound versus the molar concentration of 99m TcP2045 using the GraphPad Prism Software (San Diego, CA, USA).
For internalization assays, A-427 cells were infected with Ad-hSSTr2 or Ad-HAhSSTr2 at 10 MOI and 24 h later seeded in 96-well plates. Twenty-four hours later, Tc-P2045 was added to the wells at various concentrations (0.1-60 nM). The cells were incubated for 2 h at 371C and then the media removed. An excess (41000 nM) of unlabeled P2045 was added to the wells to demonstrate specific binding. The cells were washed twice with PBS and then rinsed with Hank's balanced salt solution (HBSS) containing 20 mmol/l sodium acetate (pH 4.0) to remove cell surface radioactivity. The cells were then harvested and counted in a gamma counter to determine the amount of internalized radioactivity. The data are presented as the specific amount of internalized radioactivity as a percentage of the total radioactivity added.
In vitro binding of 99m Tc-anti-HA to infected A-427 cells These assays were conducted using the same methods described above for the internalization of 99m Tc-P2045. In these studies, the concentration of 99m Tc-anti-HA ranged from 0.25 to 35 nM and the cells were incubated at both 01C and 371C. The imaging of the 96-well plates after incubation at 371C was performed as previously described. 30, 33 After imaging, the cells were harvested and counted in a gamma counter and the data are presented as the specific amount of cell-associated radioactivity as a percentage of the total radioactivity added. as previously described. 24 Immediately after the imaging session, the animals were killed and the tissues counted in a well-type gamma counter.
In a second experiment, female athymic nude mice were implanted subcutaneously in each rear flank with 2 Â 10 6 A-427 cells in a 1:1 Matrigel mixture. Three weeks after tumor cell inoculation, the right tumors were directly injected with 1 Â 10 9 pfu of Ad-HAhSSTr2 and the left tumors were directly injected with 1 Â 10 9 pfu of Ad-hSSTr2 as previously described. 24, 26 Tumor sizes ranged from 100 to 450 mg and were injected with 50 ml of the adenoviral vectors while slowly removing the needle from the tumors. Forty-eight hours after adenoviral injection, the animals were injected i.v. with 99m Tcanti-HA (mean dose¼179.0 7 30.9 mCi; 12.0 7 2.0 mg). The animals were imaged immediately for 3 min after injection and then for 20 min 25 h later with an Anger gamma camera equipped with a pinhole collimator as previously described. 24 Immediately after the imaging session, the animals were killed and the tissues counted in a well-type gamma counter.
Immunohistochemistry
Mice injected i.v. with Ad-HAhSSTr2 were killed 48 h after injection and organs cut into strips 2-3 mm in width, then fixed in 10% buffered formalin for 24 h. Tissues were processed into paraffin, then 4 mm sections were heat mounted onto positively charged slides. Sections were dewaxed and rehydrated, then blocked in 3% goat serum. Primary mouse monoclonal anti-HA antibody (Sigma, clone HA-7, St. Louis, MO, USA) was diluted 1/1000, then applied to sections for 1 h at room temperature. Sections were washed, then a fluorescent anti-mouse secondary antibody (Alexa-488 goat antimouse, Molecular Probes, Eugene, OR, USA) was applied at 1/1000 dilution for 1 h at room temp. Nuclei were stained with Hoescht 33342 (Molecular Probes, Eugene, OR, USA) for 10 min at room temperature. Negative controls included tissues from an uninfected mouse, and sections incubated without primary antibody. Immunofluorescent images were obtained using Olympus IX 70 inverted microscope or Leitz Orthoplan with epifluorescence optics and Photometrics Sensys cooled CCD, high resolution, monochromatic camera (Roper Scientific, Tucson, AZ, USA) and IPLab Spectrum Image Analysis software (Scanalytics, Fairfax, VA, USA).
Statistical analysis
Statistical comparisons were performed with the Statistical Analysis System program (Release 8.0,. SAS Institute Inc., Cary, NC, USA) using one-and two-way analysis of variance protocols (Proc GLM). Treatment means were also compared using the least-squares means protocol, and considered different at Po0.05. A log transformation was used to stabilize the variance, when means were highly different and when the coefficient of variation was constant among the groups.
